The healthcare diagnostics company has published a circular seeking shareholder approval for a fundraising to support its commercial growth and scale-up of its Tutivia product.
The healthcare diagnostics company reports a change in major shareholdings, with several investment firms increasing their stakes.
The healthcare company has received Medicare coverage for its Tutivia diagnostic test, which will improve patient access to the product.
The healthcare diagnostics company reports a significant increase in orders for its Tutivia test, as it awaits a key Medicare coverage decision. The firm also notes progress in its PTRA collaboration with Thermo Fisher.
The healthcare diagnostics company announces a change in major shareholding, with no clear impact on the business.
The healthcare company provides an update on the regulatory process for its key diagnostic test, leading to a delay in revenue recognition.
Diagnostics company Verici Dx partners with Thermo Fisher to launch innovative kidney transplant assay.
Diversified healthcare diagnostics company delivers strong revenue growth and improved financial position.
Diagnostics company to report interim results and provide business update
Diagnostic company Verici Dx achieves milestone in partnership with Thermo Fisher, enabling further development and commercialization of its organ transplant technology.